The landscape of managing diabetes is evolving with the arrival of transdermal GLP-1 delivery . These innovative devices offer a potentially less invasive alternative to shots for individuals dealing with diabetes 2. They deliver GLP-1 medication directly through the dermis , bypassing the need for daily injections and perhaps increasing compliance